Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

NCT06493019 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Anal Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Paclitaxel
DRUG: Carboplatin
RADIATION: Radiation
DRUG: Pembrolizumab

Sponsor

Dustin Deming

Collaborators

[object Object]
[object Object]